{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:10:56Z","timestamp":1760775056275,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bmcl.2022.128701","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T12:50:53Z","timestamp":1648212653000},"page":"128701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pyrrolidinyl benzofurans and benzodioxanes: Selective \u03b14\u03b22 nicotinic acetylcholine receptor ligands with different activity profiles at the two receptor stoichiometries"],"prefix":"10.1016","volume":"65","author":[{"given":"Rebecca","family":"Appiani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Pallavicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman K.","family":"Hamouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano","family":"Bolchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2022.128701_b0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2012.08.012","article-title":"Nicotinic acetylcholine receptors: from basic science to therapeutics","volume":"137","author":"Hurst","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmcl.2022.128701_b0010","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1007\/s00213-018-4921-9","article-title":"The contribution of agonist and antagonist activities of \u03b14\u03b22* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data","volume":"235","author":"Rollema","year":"2018","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.bmcl.2022.128701_b0015","doi-asserted-by":"crossref","first-page":"8204","DOI":"10.1021\/jm401937a","article-title":"Recent developments in novel antidepressants targeting \u03b14\u03b22-nicotinic acetylcholine receptors","volume":"57","author":"Yu","year":"2014","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2022.128701_b0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/7854_2020_135","article-title":"Behavioral and molecular basis of cholinergic modulation of pain: focus on nicotinic acetylcholine receptors","volume":"45","author":"Toma","year":"2020","journal-title":"Curr Topics Behav Neurosci."},{"key":"10.1016\/j.bmcl.2022.128701_b0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41386-019-0475-8","article-title":"Promoting activity of (\u03b14)3(\u03b22)2 nicotinic cholinergic receptors reduces ethanol consumption","volume":"45","author":"Wang","year":"2020","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.bmcl.2022.128701_b0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41586-018-0081-7","article-title":"Structural principles of distinct assemblies of the human \u03b14\u03b22 nicotinic receptor","volume":"557","author":"Walsh","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2022.128701_b0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.neuron.2019.07.030","article-title":"Agonist selectivity and ion permeation in the \u03b13\u03b24 ganglionic nicotinic receptor","volume":"104","author":"Gharpure","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.bmcl.2022.128701_b0040","first-page":"1009","article-title":"Homology modelling and molecular dynamics simulations of transmembrane domain structure of human neuronal nicotinic acetylcholine receptor","volume":"88","author":"Saladino","year":"2005","journal-title":"Biophys."},{"key":"10.1016\/j.bmcl.2022.128701_b0045","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.bbrc.2008.02.080","article-title":"Modelling of full-length human \u03b14\u03b22 nicotinic receptor by fragmental approach and analysis of its binding modes","volume":"369","author":"Pedretti","year":"2008","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1016\/j.bmcl.2022.128701_b0050","doi-asserted-by":"crossref","unstructured":"Morales-Perez CL, Noviello CM, Hibbs RE. X-ray structure of the human \u03b14\u03b22 nicotinic receptor. Nature. 2016;538-411-415.","DOI":"10.1038\/nature19785"},{"key":"10.1016\/j.bmcl.2022.128701_b0055","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1074\/jbc.M112.436337","article-title":"Molecular determinants of subtype-selective efficacies of cytisine and the novel compound NS3861 at heteromeric nicotinic acetylcholine receptors","volume":"288","author":"Harps\u00f8e","year":"2013","journal-title":"J Biol Chem."},{"key":"10.1016\/j.bmcl.2022.128701_b0060","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.3390\/molecules26123603","article-title":"Determinants for \u03b14\u03b22 vs \u03b13\u03b24 subtype selectivity of pyrrolidine-based nAChRs ligands: a computational perspective with focus on recent cryo-EM receptor structures","volume":"26","author":"Bavo","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2022.128701_b0065","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.chempr.2018.05.007","article-title":"Unlocking nicotinic selectivity via direct C-H functionalization of (-)-cytisine","volume":"4","author":"Rego Campello","year":"2018","journal-title":"Chem."},{"key":"10.1016\/j.bmcl.2022.128701_b0070","doi-asserted-by":"crossref","first-page":"10531","DOI":"10.1021\/acs.jmedchem.8b01052","article-title":"Potent antiglioblastoma agents by hybridizing the onium-alkyloxy-stilbene based structures of an \u03b17-nAChR, \u03b19-nAChR antagonist and of a pro-oxidant mitocan","volume":"61","author":"Bavo","year":"2018","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2022.128701_b0075","first-page":"1474","article-title":"Variations in binding among several agonists at two stoichiometries of the neuronal, \u03b14\u03b22 nicotinic receptor","volume":"134","author":"Da Siva","year":"2012","journal-title":"J Am Chem Soc."},{"key":"10.1016\/j.bmcl.2022.128701_b0080","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1021\/cb400937d","article-title":"Selective ligand behaviors provide new insights into agonist activation of nicotinic acethylcholine receptors","volume":"9","author":"Marotta","year":"2014","journal-title":"ACS Chem Biol."},{"key":"10.1016\/j.bmcl.2022.128701_b0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bcpt.12361","article-title":"Targeting \u03b14\u03b22 nicotinic acetylcholine receptors in central nervous system disorders: perspectives on positive allosteric modulation as a therapeutic approach","volume":"116","author":"Grupe","year":"2015","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"10.1016\/j.bmcl.2022.128701_b0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00213-016-4475-7","article-title":"Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator NS9283","volume":"234","author":"Maurer","year":"2017","journal-title":"Psychopharmacology."},{"key":"10.1016\/j.bmcl.2022.128701_b0095","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/bph.13745","article-title":"Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors","volume":"175","author":"Wang","year":"2018","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.bmcl.2022.128701_b0100","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00018-018-2993-7","article-title":"Potentiation of a neuronal nicotinic receptor via pseudo-agonist site","volume":"76","author":"Mazzaferro","year":"2019","journal-title":"Cell Mol Life Sci."},{"key":"10.1016\/j.bmcl.2022.128701_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108008","article-title":"Advances in the in vitro and in vivo pharmacology of alpha4beta2 nicotinic receptor positive allosteric modulators","volume":"168","author":"Wilkerson","year":"2020","journal-title":"Neuropharmacol."},{"key":"10.1016\/j.bmcl.2022.128701_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108568","article-title":"Potentiation of (\u03b14)2(\u03b22)3, but not (\u03b14)3(\u03b22)2 nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms","volume":"190","author":"Hamouda","year":"2021","journal-title":"Neuropharmacol."},{"key":"10.1016\/j.bmcl.2022.128701_b0115","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bmcl.2008.12.002","article-title":"5-(2-Pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes: Synthesis of all the stereoisomers and \u03b14\u03b22 nicotinic affinity","volume":"19","author":"Pallavicini","year":"2009","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmcl.2022.128701_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112419","article-title":"1,4-Benzodioxane, an evergreen, versatile scaffold in medicinal chemistry: A review of its recent applications in drug design","volume":"200","author":"Bolchi","year":"2020","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.bmcl.2022.128701_b0125","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ejmech.2016.10.048","article-title":"From pyrrolidinyl-benzodioxane to pyrrolidinyl-pyridodioxanes, or from unselective antagonism to selective partial agonism at \u03b14\u03b22 nicotinic acetylcholine receptor","volume":"125","author":"Bolchi","year":"2017","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.bmcl.2022.128701_b0130","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s00213-020-05536-6","article-title":"Behavioural and pharmacological profiles of zebrafish administrated pyrrolidinyl benzodioxanes and prolinol aryl ethers with high affinity for heteromeric nicotinic acetylcholine receptors","volume":"237","author":"Braida","year":"2020","journal-title":"Psychopharmacol."},{"key":"10.1016\/j.bmcl.2022.128701_b0135","doi-asserted-by":"crossref","first-page":"7588","DOI":"10.1021\/jm200937t","article-title":"Unichiral 2-(2\u2032-pyrrolidinyl)-1,4-benzodioxanes: the 2R,2\u2032S diastereomer of the N-methyl-7-hydroxy analogue is a potent \u03b14\u03b22- and \u03b16\u03b22-nicotinic acetylcholine receptor partial agonist","volume":"54","author":"Bolchi","year":"2011","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2022.128701_b0140","doi-asserted-by":"crossref","first-page":"15668","DOI":"10.1021\/acs.jmedchem.0c01150","article-title":"Modifications at C(5) of 2-(2-pyrrolidinyl)-substituted 1,4-benzodioxane elicit potent \u03b14\u03b22 nicotinic acetylcholine receptor partial agonism with high selectivity over the \u03b13\u03b24 subtype","volume":"63","author":"Bavo","year":"2020","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2022.128701_b0145","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1021\/acs.jmedchem.5b00904","article-title":"Chemistry and pharmacology of a series of unichiral analogues of 2-(2pPyrrolidinyl)-1,4-benzodioxane, prolinol phenyl ether, and prolinol 3-pyridyl ether designed as \u03b14\u03b22-nicotinic acetylcholine receptor agonists","volume":"58","author":"Bolchi","year":"2015","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2022.128701_b0150","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1016\/j.bmcl.2016.10.078","article-title":"Novel 5-substituted 3-hydroxyphenyl and 3-nitrophenyl ethers of S-prolinol as \u03b14\u03b22-nicotinic acetylcholine receptor ligands","volume":"26","author":"Bolchi","year":"2016","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmcl.2022.128701_b0155","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1021\/jm0492406","article-title":"Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)- pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing \u03b12 subunits","volume":"48","author":"Wei","year":"2005","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2022.128701_b0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/1568026043451438","article-title":"Design of ligands for Nicotinic acetylcholine receptors: the quest for selectivity","volume":"4","author":"Bunnelle","year":"2004","journal-title":"Curr Top Med Chem."},{"key":"10.1016\/j.bmcl.2022.128701_b0165","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1016\/S0960-894X(97)10080-4","article-title":"Novel 2-(2\u2019furo[3,2-b]pyridinyl)pyrrolidines: potent neuronal nicotinic acethylcholine receptor ligands","volume":"7","author":"Elliot","year":"1997","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmcl.2022.128701_b0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0031-6865(99)00023-0","article-title":"Structural aspects of high affinity ligands for the \u03b14\u03b22 neuronal nicotinic receptor","volume":"74","author":"Dart","year":"2000","journal-title":"Pharm Acta Helv."},{"key":"10.1016\/j.bmcl.2022.128701_b0175","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1021\/ol1017799","article-title":"Diamine-free lithiation-trapping of N-Boc heterocycles using s-BuLi in THF","volume":"12","author":"Barker","year":"2010","journal-title":"Org Lett."},{"key":"10.1016\/j.bmcl.2022.128701_b0180","doi-asserted-by":"crossref","first-page":"8778","DOI":"10.1021\/jacs.9b04325","article-title":"\u03b1-Functionalization of cyclic secondary amines: Lewis acid promoted addition of organometallics to transient imines","volume":"141","author":"Paul","year":"2019","journal-title":"J Am Chem Soc."},{"key":"10.1016\/j.bmcl.2022.128701_b0185","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1039\/C8OB03102A","article-title":"A protecting group-free divergent synthesis of natural benzofurans via one-pot synthesis of 2-bromo-6-hydroxybenzofurans","volume":"17","author":"Sivaraman","year":"2019","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmcl.2022.128701_b0190","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.1074\/jbc.M116.771246","article-title":"Unraveling amino acid residues critical for allosteric potentiation of (\u03b14)3(\u03b2)2-type nicotinic acetylcholine receptor responses","volume":"292","author":"Wang","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2022.128701_b0195","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/s41598-018-19790-4","article-title":"LY2087101 and dFBr share transmembrane binding sites in the (\u03b14)3(\u03b22)2 nicotinic acetylcholine receptor","volume":"8","author":"Deba","year":"2018","journal-title":"Sci Rep."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22001779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22001779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:44:54Z","timestamp":1760773494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X22001779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":39,"alternative-id":["S0960894X22001779"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128701","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrrolidinyl benzofurans and benzodioxanes: Selective \u03b14\u03b22 nicotinic acetylcholine receptor ligands with different activity profiles at the two receptor stoichiometries","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128701"}}